Loading company…
Xiuzheng Biopharmaceutical conducts medical research and develops biopharmaceutical products and cell technology applications.
Founded in 2015 and based in Taizhou, Xiuzheng Biopharmaceutical conducts medical research and develops technical services and cell technology applications. Its patented technologies include polyethylene glycol non-covalently bound L-asparaginase and site-directed modified ranibizumab. In August 2025, it raised venture funding from Taizhou Shengxin Industry Fund, Beijing Hongjia Private Fund Management, Xiuzheng Biopharmaceutical (Taizhou) Co., Ltd., Hangzhou Qianhui Technology Development Partnership and Taizhou Jiayuan Investment Development Co., Ltd.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Xiuzheng Biopharmaceutical (Taizhou) Co., Ltd.? This is my company